Registry of Lobbyists

Registration - In-house Corporation

ASTRAZENECA CANADA INC. / JEAN-PAUL BEDARD, DIRECTEUR EXECUTIF, AFFAIRES EXTERNES

Registration Information

In-house Corporation name: ASTRAZENECA CANADA INC.
Responsible Officer Name: JEAN-PAUL BEDARD, DIRECTEUR EXECUTIF, AFFAIRES EXTERNES 
Initial registration start date: 1996-03-29
Registration status: Inactive
Registration Number: 780797-12114

Version 1 of 1 (1996-03-29 to 1997-01-10)

Version 1 of 1 (1996-03-29 to 1997-01-10) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Information about Lobbyist and Corporation

Corporation: ASTRAZENECA CANADA INC.
1004 MIDDLEGATE ROAD
MISSISSAUGA, ON  L4Y 1M4
Canada
Telephone number: 514-633-7876
Fax number: 514-631-0047  
Responsible officer name and position during the period of this registration: JEAN-PAUL BEDARD, DIRECTEUR EXECUTIF, AFFAIRES EXTERNES  
Description of activities: RESEARCH, DEVELOPMENT, SALES AND MARKETING OF PATENTED HUMAN PHARMACEU TICAL PRODUCTS.
 
Parent: The corporation is not a subsidiary of any other parent corporations.
Coalition The corporation is not a member of a coalition.
Subsidiary: The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking.
Other direct interests The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

B. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Aboriginal Affairs and Northern Development Canada, Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada, National Defence (DND), Patented Medicine Prices Review Board (PMPRB)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Health, Industry, Intellectual Property, International Trade, Science and Technology
 
Subject Matter: Particulars: LOBBYING AND ADVOCATING COMPANY POSITIONS ON POLICIES, REGULATIONS AND STATUTES CONCERNING HEALTH/INTELLECTUAL PROPERTY PROTECTION/TRADE AND EXPORT.PARLIAMENTARY REVIEW C-91ALL REGULATIONS WITH HEALTH PROTECTION BRANCHRELATED ISSUES AFFECTING MARKET ACCESS.




Date Modified: